Friday, April 5, 2013
Amylin Pharmaceuticals To Shut San Diego Operations
Usually, when a company is acquired, it's great news for investors--and employees. However, it looks like the acquisition of San Diego's Amylin Pharmaceuticals by Bristol-Myers Squibb is turning out not-so-great for employees in the location, after news that Bristol-Myers Squibb plans to close its San Diego operations, resulting in the loss of hundreds of jobs. The move was first reported by the U-T San Diego. Amylin Pharmaceuticals as a developer of diabetes drugs.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More